$CCO

White Raymond T. sold $6.0M of CCO (indirect holdings)

White Raymond T. sold 2,500,900 indirectly-held shares of Clear Channel Outdoor Holdings, Inc. (CCO) at an average of $2.40 ($2.40–$2.40, $5.99M total) across 4 trades on 2026-06-15.

Original reporting
SEC EDGAR · White Raymond T.
Published Jun 17, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCO
Neutral
medium confidence
Mentioned
$CCO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCONeutralLow
01

Why it matters

A director open-market sale of ~2.5M shares at about $2.40 is newly disclosed; absent other catalysts, it mainly affects sentiment rather than valuation fundamentals.

02

Market read

Traders may monitor for follow-on insider activity or unusual volume, but the filing alone is unlikely to drive a durable move without additional company news.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no information on whether other insiders/funds are buying, nor any concurrent operational or financial updates that would validate a negative read-through.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-17; sale executed 2026-06-15.

Background

The article is a SEC Form 4 insider transaction disclosure for Clear Channel Outdoor Holdings, Inc.

Company-level read

Ticker impact

$CCONeutralMedium confidence
Context

Clear Channel Outdoor Holdings disclosed an insider director open-market sale of 2,500,900 shares at ~$2.3954–$2.4000 on 2026-06-15 via Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and should fade unless follow-on selling or new fundamentals emerge.

Evidence & confidence

Form 4 insider sales can influence short-term sentiment, but the article provides no accompanying company-specific catalyst (earnings, guidance, deal, or regulatory action). The sale is sizable in shares, yet the disclosure alone rarely drives sustained repricing.

Market effects

Minimal; insider selling in a single media/OOH name typically does not reset sector expectations without additional sector/regulatory context.

None indicated; disclosure is company-specific.

None indicated; no cross-border transaction or global regulatory action mentioned.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing rather than a bearish signal, especially since the filing lacks any stated reason or linkage to company performance.

Key entities

  • Clear Channel Outdoor Holdings, Inc.

    Subject of the Form 4 insider sale disclosure (CCO).

  • White Raymond T.

    Director who sold 2,500,900 shares across four trades; holdings after transaction: 0 shares; no 10b5-1 plan cited.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Cameco’s Westinghouse Stake Could Be Worth More Than $24.5 Billion

Cameco (CCO) shares rose 3.6% on reports that its co-owned Westinghouse is targeting a $50B US IPO, potentially valuing Cameco's 49% stake at over $24.5B. Cameco's Q2 earnings showed a Westinghouse net loss, but the company attributes this to project-related revenue fluctuations. Westinghouse's adjusted EBITDA fell to C$163M in Q2 from C$352M a year earlier. Cameco's P/E ratio has not significantly re-rated following the IPO news, with estimates ranging from $15B to $50B for Westinghouse.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).